(MedPage Today) -- Incretin therapy increased pancreatic mass and beta cell mass in patients with type 2 diabetes, potentially putting patients at risk for malignancies, researchers found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment